YNL146W Antibody

What is YNL146W and why is it relevant to research?

YNL146W is a hypothetical protein-coding gene found in Saccharomyces cerevisiae S288C (baker's yeast), corresponding to Entrez Gene ID 855576. This gene encodes a protein with UniProt Number P53906, which remains largely uncharacterized but is of interest in fundamental yeast cellular biology research. Studying this protein helps elucidate basic cellular mechanisms in yeast, which often have conserved analogues in higher eukaryotes. Antibodies against this protein serve as important research tools for detecting, quantifying, and isolating this protein in experimental systems .

What are the key specifications of commercially available YNL146W antibodies?

The most commonly used YNL146W antibody is a rabbit polyclonal antibody purified using Protein A/G affinity chromatography. It is typically supplied unconjugated, allowing researchers flexibility in experimental design. The antibody is raised against a recombinant immunogen derived from Saccharomyces cerevisiae (strain ATCC 204508/S288c) YNL146W protein. Its IgG isotype and species reactivity specific to yeast make it suitable for specialized yeast research applications .

What are the validated applications for YNL146W antibody?

Current research indicates that YNL146W antibody has been validated for two primary applications:

• Enzyme-Linked Immunosorbent Assay (ELISA): For quantitative detection of YNL146W protein in yeast lysates

• Western Blotting (WB): For semi-quantitative detection of the target protein in denatured samples

These applications have been empirically validated through quality control testing by suppliers. Other potential applications may include immunoprecipitation and immunocytochemistry, though these would require additional validation by individual researchers .

What are the optimal storage and handling conditions for YNL146W antibody?

YNL146W antibody requires specific storage conditions to maintain its binding efficacy and specificity. The antibody should be stored at either -20°C or -80°C for long-term stability. For shipping purposes, suppliers typically use blue ice to maintain appropriate temperature. When working with the antibody, researchers should:

• Avoid repeated freeze-thaw cycles (aliquot upon first thaw)

• Use sterile technique when handling

• Centrifuge briefly before opening vials to collect material that may have adhered to the cap or sides

• Keep on ice during experimental procedures

• Return to recommended storage conditions immediately after use

How should YNL146W antibody be validated before experimental use?

Prior to employing YNL146W antibody in key experiments, thorough validation is essential to ensure specificity and sensitivity. A comprehensive validation approach should include:

• Positive control testing using the supplied recombinant immunogen protein (200μg typically provided)

• Negative control testing using the pre-immune serum (1ml typically provided)

• Concentration gradient testing to determine optimal antibody dilution for your specific application

• Cross-reactivity assessment with related yeast proteins

• If possible, validation using a YNL146W knockout strain as a negative control

These validation steps are critical for confirming that experimental results reflect true YNL146W detection rather than non-specific binding or background signal .

What are the optimal conditions for Western blotting with YNL146W antibody?

For optimal results in Western blot applications with YNL146W antibody, researchers should consider the following protocol optimizations:

As with all polyclonal antibodies, batch-to-batch variation may necessitate dilution optimization for each new lot received .

How does the polyclonal nature of YNL146W antibody impact experimental design?

The polyclonal nature of commercially available YNL146W antibodies has significant implications for experimental design and data interpretation:

• Multiple epitope recognition: Polyclonal antibodies recognize multiple epitopes on the target protein, potentially increasing sensitivity but also raising the possibility of cross-reactivity.

• Lot-to-lot variability: Different production lots may have variations in the exact epitope recognition patterns, necessitating consistent use of the same lot for comparative studies.

• Signal amplification: Recognition of multiple epitopes can enhance signal strength, making polyclonal antibodies advantageous for detecting low-abundance proteins.

• Background considerations: More stringent blocking and washing steps may be required compared to monoclonal antibodies due to the potentially broader binding profile.

• Reproducibility challenges: The heterogeneous nature of polyclonal antibodies may impact reproducibility between different batches or suppliers.

Researchers should account for these characteristics when designing experiments and consider including appropriate controls to address potential variability .

What steps should be taken if YNL146W antibody shows weak signal or high background?

When encountering weak signal or high background issues with YNL146W antibody, systematic troubleshooting is essential:

For weak signal:

• Increase antibody concentration (within reasonable limits)

• Extend incubation time at 4°C

• Increase protein loading on gel/blot

• Use enhanced sensitivity detection reagents

• Ensure protein of interest is not degraded in samples

• Verify transfer efficiency with reversible staining

• Check expression levels of target protein in your specific strain

For high background:

• Increase blocking time and concentration

• Add 0.1-0.5% Tween-20 to washing buffer

• Increase number and duration of washes

• Decrease antibody concentration

• Use pre-adsorbed secondary antibodies

• Include 0.1-1% BSA in antibody diluent

• Pre-incubate membrane with pre-immune serum supplied with the antibody

What controls are essential when using YNL146W antibody in research applications?

Rigorous experimental design requires appropriate controls to ensure valid interpretation of results:

• Positive control: Use of supplied recombinant immunogen protein (200μg)

• Negative control: Pre-immune serum application to identical samples

• Loading control: Detection of housekeeping protein (e.g., actin) for normalization

• Blocking peptide control: Pre-incubation of antibody with excess antigen to confirm specificity

• Strain controls: Comparing wild-type to YNL146W deletion strains when available

• Secondary antibody-only control: To identify non-specific binding of secondary antibody

These controls should be systematically incorporated into experimental designs to confirm specificity and validate observations made with YNL146W antibody .

How can YNL146W antibody be used in co-immunoprecipitation experiments?

Co-immunoprecipitation (Co-IP) using YNL146W antibody can reveal protein-protein interactions involving this hypothetical yeast protein. While not explicitly validated for this application by suppliers, researchers can adapt the following methodology:

• Cell lysis: Use gentle, non-denaturing lysis buffers (e.g., 20mM Tris-HCl pH 7.5, 150mM NaCl, 1mM EDTA, 1% NP-40) with protease/phosphatase inhibitors.

• Pre-clearing: Incubate lysates with protein A/G beads and pre-immune serum to reduce non-specific binding.

• Immunoprecipitation: Incubate pre-cleared lysate with YNL146W antibody (typically 2-5μg per mg of protein) overnight at 4°C.

• Capture: Add protein A/G beads and incubate for 2-4 hours at 4°C with gentle rotation.

• Washing: Perform 4-6 stringent washes with lysis buffer to remove non-specific interactions.

• Elution and analysis: Elute with SDS sample buffer and analyze by Western blot for both YNL146W and potential interacting proteins.

• Controls: Include IgG control, input samples, and when possible, YNL146W knockout strains as negative controls.

This approach can help identify novel protein interactions and functional roles for the largely uncharacterized YNL146W protein in yeast cellular processes .

What emerging techniques could enhance research utilizing YNL146W antibody?

Several advanced techniques could potentially expand the utility of YNL146W antibody in yeast research:

• Proximity Labeling: Adapting techniques like BioID or APEX2 by fusing these enzymes to anti-YNL146W scFvs could help identify proximal proteins in the native cellular context.

• Super-Resolution Microscopy: Combining YNL146W antibody with fluorophore-conjugated secondary antibodies optimized for techniques like STORM or PALM could provide detailed subcellular localization information.

• Antibody Engineering: Developing recombinant antibody fragments (Fab, scFv) against YNL146W could improve tissue penetration and reduce background in imaging applications.

• Multiplexed Detection: Integration of YNL146W antibody into multiplexed detection systems using oligonucleotide-conjugated antibodies and next-generation sequencing could enable simultaneous detection of multiple proteins.

• Single-Cell Applications: Adapting YNL146W antibody for use in single-cell proteomics approaches could reveal cell-to-cell variation in YNL146W expression and function.

These emerging approaches represent the future direction of research utilizing YNL146W antibody, potentially yielding deeper insights into its cellular functions .

How do polycolonal YNL146W antibodies compare with emerging technologies for protein detection?

Traditional polyclonal antibodies against YNL146W can be contrasted with newer technologies for protein detection and analysis:

Recent advances in antibody design using computational approaches and protein large language models (such as MAGE) may eventually lead to the development of more specific antibodies against YNL146W, potentially addressing some of the limitations of current polyclonal versions .

What factors should researchers consider when selecting YNL146W antibody for specific applications?

When selecting the optimal YNL146W antibody for specific research applications, consider these critical factors:

• Validated applications: Ensure the antibody has been validated for your intended application (ELISA, WB, etc.).

• Species compatibility: Confirm reactivity with your specific yeast strain, as strain variations may affect epitope recognition.

• Antibody format: Consider whether unconjugated antibody meets your needs or if direct conjugates would be advantageous.

• Sensitivity requirements: Assess whether the detection limit of the antibody meets the expected expression level of YNL146W in your experimental system.

• Supporting validation data: Review available data on specificity, including Western blot images showing a single band at the expected molecular weight.

• Lot consistency: For longitudinal studies, consider suppliers that provide information on lot-to-lot consistency or offer large lot reservations.

• Controls provided: Evaluate whether the antibody comes with appropriate controls (pre-immune serum, recombinant antigen).

• Technical support: Consider the level of technical support and documentation provided by the supplier.

Thoughtful evaluation of these factors will help ensure selection of the most appropriate YNL146W antibody for specific research needs .